Comparison of surgical effectiveness: kidney sparing surgery for upper tract urothelial carcinoma.

IF 2.1 3区 医学 Q2 UROLOGY & NEPHROLOGY Current Opinion in Urology Pub Date : 2025-01-01 Epub Date: 2024-11-07 DOI:10.1097/MOU.0000000000001248
Hugo W Schuil, Orlane J A Figaroa, Joyce Baard, David A Lifshitz, Faridi S Jamaludin, Guido M Kamphuis
{"title":"Comparison of surgical effectiveness: kidney sparing surgery for upper tract urothelial carcinoma.","authors":"Hugo W Schuil, Orlane J A Figaroa, Joyce Baard, David A Lifshitz, Faridi S Jamaludin, Guido M Kamphuis","doi":"10.1097/MOU.0000000000001248","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose of review: </strong>This review provides an overview of the recent publications on kidney-sparing-surgery (KSS) for upper tract urothelial carcinoma (UTUC), an alternative to radical nephroureterectomy (RNU) for an increasing number of indications.</p><p><strong>Recent findings: </strong>Recent studies highlight comparable survival outcomes between KSS [ureterorenoscopy with tumour ablation (URS) or segmental ureteral resection (SUR)] and RNU, even in high-risk UTUC patients. KSS has shown to preserve renal function without significantly compromising oncologic control in appropriately selected patients. Included literature also researched surgical complications, surveillance strategies, such as second-look ureteroscopy, and comparative cost analyses.</p><p><strong>Summary: </strong>Over the past two and a half years, studies have emphasized the growing usage of URS and SUR in treating selected UTUC patients. Recent literature has remarkably included relatively large numbers of typically high-risk patients with features such as high-grade tumours, stage >Ta, multifocality, and hydronephrosis with acceptable results. Further research should expand on the different indications for KSS, its postoperative surveillance and comparative economic analyses.</p>","PeriodicalId":11093,"journal":{"name":"Current Opinion in Urology","volume":" ","pages":"58-67"},"PeriodicalIF":2.1000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Opinion in Urology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/MOU.0000000000001248","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/11/7 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose of review: This review provides an overview of the recent publications on kidney-sparing-surgery (KSS) for upper tract urothelial carcinoma (UTUC), an alternative to radical nephroureterectomy (RNU) for an increasing number of indications.

Recent findings: Recent studies highlight comparable survival outcomes between KSS [ureterorenoscopy with tumour ablation (URS) or segmental ureteral resection (SUR)] and RNU, even in high-risk UTUC patients. KSS has shown to preserve renal function without significantly compromising oncologic control in appropriately selected patients. Included literature also researched surgical complications, surveillance strategies, such as second-look ureteroscopy, and comparative cost analyses.

Summary: Over the past two and a half years, studies have emphasized the growing usage of URS and SUR in treating selected UTUC patients. Recent literature has remarkably included relatively large numbers of typically high-risk patients with features such as high-grade tumours, stage >Ta, multifocality, and hydronephrosis with acceptable results. Further research should expand on the different indications for KSS, its postoperative surveillance and comparative economic analyses.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
手术效果比较:上尿路尿道癌的保肾手术。
综述目的:本综述概述了最近发表的有关上尿路上皮癌(UTUC)保肾手术(KSS)的文章,该手术是根治性肾切除术(RNU)的替代方案,适用于越来越多的适应症:最近的研究表明,KSS[输尿管镜加肿瘤消融术(URS)或节段性输尿管切除术(SUR)]与根治性肾切除术(RNU)的生存率相当,即使是高危UTUC患者也不例外。事实证明,在适当选择患者的情况下,KSS 既能保留肾功能,又不会明显影响肿瘤控制。摘要:在过去两年半的时间里,研究强调 URS 和 SUR 在治疗经选择的 UTUC 患者中的应用越来越广泛。最近的文献显著纳入了相对较多的典型高危患者,这些患者具有高级别肿瘤、分期>Ta、多发病和肾积水等特征,且治疗效果尚可。进一步的研究应扩展 KSS 的不同适应症、术后监测和经济比较分析。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Current Opinion in Urology
Current Opinion in Urology 医学-泌尿学与肾脏学
CiteScore
5.00
自引率
4.00%
发文量
140
审稿时长
6-12 weeks
期刊介绍: ​​​​​​​​Current Opinion in Urology delivers a broad-based perspective on the most recent and most exciting developments in urology from across the world. Published bimonthly and featuring ten key topics – including focuses on prostate cancer, bladder cancer and minimally invasive urology – the journal’s renowned team of guest editors ensure a balanced, expert assessment of the recently published literature in each respective field with insightful editorials and on-the-mark invited reviews.
期刊最新文献
Integration of novel artificial intelligence tools in pediatric urologic practice. The role of surgical resection of the primary tumor in metastatic upper tract urothelial carcinoma: a systematic review and meta-analysis. Current role of salvage radiotherapy in oligometastatic prostate cancer at the time of recurrence. Generative artificial intelligence in oncology. Medical therapy for male infertility.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1